ENGINEERED HISTONE DEACETYLASE (HDAC) INHIBITOR NANOPARTICLES FOR DURABLE SUPPRESSION OF ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER

$114,921FY2010Department of DefenseDOD

Yale Univ

Investigators